PPARγ activation sensitizes MSS gastrointestinal cancer cells to PD1 blockage
{{output}}
Objectives: Antibodies (Abs) against immune checkpoint "programmed-cell-death-1" (PD1) achieve benefit in patients with microsatellite instable (MSI), immunologically "hot" gastrointestinal (GI) cancers, but fail in cases wit... ...
